Spontaneous Autoimmunity in the Absence of IL-2 Is Driven by Uncontrolled Dendritic Cells

被引:9
|
作者
Isakson, Sara H. [1 ]
Katzman, Shoshana D. [1 ]
Hoyer, Katrina K. [1 ]
机构
[1] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA
来源
JOURNAL OF IMMUNOLOGY | 2012年 / 189卷 / 04期
基金
美国国家卫生研究院;
关键词
REGULATORY T-CELLS; IN-VIVO; CUTTING EDGE; B-CELLS; MICE; INTERLEUKIN-2; COSTIMULATORS; HOMEOSTASIS; ACTIVATION; INTERFERON;
D O I
10.4049/jimmunol.1200342
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BALB/c IL-2-deficient (IL-2-KO) mice develop systemic autoimmunity, dying within 3 to 5 wk from complications of autoimmune hemolytic anemia. Disease in these mice is Th1 mediated, and IFN-gamma production is required for early autoimmunity. In this study, we show that dendritic cells (DCs) are required for optimal IFN-gamma production by T cells in the IL-2-KO mouse. Disease is marked by DC accumulation, activation, and elevated production of Th1-inducing cytokines. IL-2-KO DCs induce heightened proliferation and cytokine production by naive T cells compared with wild-type DCs. The depletion of either conventional or plasmacytoid DCs significantly prolongs the survival of IL-2-KO mice, demonstrating that DCs contribute to the progression of autoimmunity. Elimination of Th1-inducing cytokine signals (type 1 IFN and IL-12) reduces RBC-specific Ab production and augments survival, indicating that cytokines derived from both plasmacytoid DCs and conventional DCs contribute to disease severity. DC activation likely precedes T cell activation because DCs are functionally activated even in an environment lacking overt T cell activation. These data indicate that both conventional and plasmacytoid DCs are critical regulators in the development of this systemic Ab-mediated autoimmune disease, in large part through the production of IL-12 and type 1 IFNs. The Journal of Immunology, 2012, 189: 1585-1593.
引用
收藏
页码:1585 / 1593
页数:9
相关论文
共 50 条
  • [1] IL-2 immunotherapy for targeting regulatory T cells in autoimmunity
    Valentina Lykhopiy
    Vanshika Malviya
    Stephanie Humblet-Baron
    Susan M. Schlenner
    Genes & Immunity, 2023, 24 (5): : 248 - 262
  • [2] IL-2 immunotherapy for targeting regulatory T cells in autoimmunity
    Lykhopiy, Valentina
    Malviya, Vanshika
    Humblet-Baron, Stephanie
    Schlenner, Susan M.
    GENES AND IMMUNITY, 2023, 24 (05) : 248 - 262
  • [3] IL-2 mediates adjuvant effect of dendritic cells
    Granucci, F
    Andrews, DM
    Degli-Esposti, MA
    Ricciardi-Castagnoli, P
    TRENDS IN IMMUNOLOGY, 2002, 23 (04) : 169 - 171
  • [4] IL-2 modulates generation and function of dendritic cells
    不详
    IMMUNOBIOLOGY, 2004, 209 (4-6) : 406 - 407
  • [5] Revisiting the role of IL-2 in autoimmunity
    Dooms, Hans
    Abbas, Abut K.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2010, 40 (06) : 1538 - 1540
  • [6] Engineering IL-2 for immunotherapy of autoimmunity and cancer
    Hernandez, Rosmely
    Poder, Janika
    LaPorte, Kathryn M.
    Malek, Thomas R.
    NATURE REVIEWS IMMUNOLOGY, 2022, 22 (10) : 614 - 628
  • [7] Transcriptional regulation of IL-2 in health and autoimmunity
    Crispin, Jose C.
    Tsokos, George C.
    AUTOIMMUNITY REVIEWS, 2009, 8 (03) : 190 - 195
  • [8] Engineering IL-2 for immunotherapy of autoimmunity and cancer
    Rosmely Hernandez
    Janika Põder
    Kathryn M. LaPorte
    Thomas R. Malek
    Nature Reviews Immunology, 2022, 22 : 614 - 628
  • [9] IL-2 AND AUTOIMMUNITY - HYPERPRODUCTION OF IL-2 IN OBESE STRAIN CHICKENS WITH SPONTANEOUS AUTOIMMUNE-THYROIDITIS IS DUE TO A DEFECT OF NON SPECIFIC SUPPRESSOR MECHANISM
    SCHAUENSTEIN, K
    KROMER, G
    WICK, G
    JOURNAL OF LEUKOCYTE BIOLOGY, 1985, 38 (01) : 123 - 123
  • [10] ABSENCE OF IL-2 PRODUCTION IN A SCID SYNDROME WITH T-CELLS
    DISANTO, JP
    KEEVER, CA
    SMALL, TN
    NICHOLS, GL
    OREILLY, RJ
    FLOMENBERG, N
    CLINICAL RESEARCH, 1989, 37 (02): : A827 - A827